CeNeRx BioPharma raises $13M for trial of antidepression drug
CeNeRx BioPharma has raised a $13 million Series C round of financing that will fund phase 2 clinical trials of its antidepressant drug candidate.
L Capital Partners
CeNeRx BioPharma has raised a $13 million Series C round of financing that will fund phase 2 clinical trials of its antidepressant drug candidate.